covid 19 our experience in and beyond sgh
play

COVID-19 Our Experience In and Beyond SGH Kenneth Kwek CEO, - PowerPoint PPT Presentation

COVID-19 Our Experience In and Beyond SGH Kenneth Kwek CEO, Singapore General Hospital Dy GCEO SingHealth (Organisation Transformation and Informatics) Singapore Healthcare Management 2020 Singapore and SingHealth Singapore COVID-19 Timeline


  1. COVID-19 Our Experience In and Beyond SGH Kenneth Kwek CEO, Singapore General Hospital Dy GCEO SingHealth (Organisation Transformation and Informatics) Singapore Healthcare Management 2020

  2. Singapore and SingHealth

  3. Singapore COVID-19 Timeline Dorms Cleared: Phase 1: 02 Jun 2020 Start of Circuit Breaker 1 st imported 07 Aug 2020 COVID-19 case: 23 Jan 2020 Phase 2: 19 Jun 2020 1 st cluster identified in Singapore 1 st migrant worker diagnosed

  4. Framework Capacity Capability COVID-19 Management Command Culture

  5. Framework Capacity Capability COVID-19 Management Command Culture

  6. Creating Capacity Attempt to create capacity in anticipation of need Segregated flows for COVID-19 and non-COVID-19 cases C A P A C I T Y Patients and colleagues must be kept safe Capacity must be fit for purpose • Isolation, safe distancing • Cohorting, shared toilets • “Good enough” – cost and speed considerations Flexibility in deployment

  7. Emergency Department Capacity Surge Capacity Phases 1-3: addition of 120 Very tight triage to ensure Existing capacity: pax non-fever cases continue ED Fever Area (11 pax) unaffected – key to diagnosis T otal Fever capacity @ 131 pax C A P A C I T Y FSA at Carpark H (+ 66 pax) Surge Capacity Phase 3 (20 Mar) ASC converted to Linkbridge to OCH converted to ED NOK fever screening area (+ 42 pax) holding area and FSA (+ 12 pax) Surge Capacity Phase 1 (25 Jan) Surge Capacity Phase 2 (09 Feb) First Covid -19 Case (23 Jan)

  8. C A P A C I T Y Inpatient Bed Capacity No.of Patients 100 150 200 250 300 350 50 0 23-… • • Activation Outram Community Hospitals beds to 26-… 29-… create more beds capacity (~250 beds) 1-… and electives admissions/surgery Deferment of non-essential SOC appointments 4-… 7-… 10-… 13-… Confirmed 16-… 19-… 22-… 25-… 28-… 2-… 5-… 8-… 11-… 14-… 17-… Daily Census of Cases in COVID-19 Isolation Wards 20-… Suspect (MOH) 23-… 26-… 29-… 1-… 4-… 7-… 10-… 13-… 16-… Maximum Capacity = 319 19-… 22-… 25-… 28-… 1-… Suspect… 4-… 7-… 10-… 13-… 16-… 19-… 22-… 25-… 28-… 31-… 3-… Total 6-… 9-… 12-… 15-… 18-… 21-… 24-… 27-… 30-… Iso Bed Capacity 3-Jul Peacetime 6-Jul Current Capacity = 85 ------- 9-Jul 12-… 15-… 18-… 21-… Acute Respiratory Infection Beds 24-… 27-… 30-… Circuit breaker 2-… 5-… Start of 8-… 160 11-… Phase 1 229 216 Phase 2

  9. Adjustment of Healthcare Services to Situation Circuit Breaker from 07 Apr – 01 Jun’20 C A P A C I T Y During Circuit Breaker (07 Apr – 01 Jun) 1 • Cases which cannot be deferred more than 2 weeks • Deployed 3 Urology OTs as COVID 19 OTs After Circuit Breaker (02 Jun onwards) 2 • Gradual ramping up of services • Cases which cannot be deferred by 4 weeks Post circuit breaker

  10. Creating New Capacity From Carpark to Ward – 50 negative pressured isolation rooms in 50 days 50 single units C A P A C I T Y • Negative-pressure • Airconditioned • Ensuite toilet and shower • Piped Oxygen • Remote monitoring • Bedside tablet

  11. Ramping Up Our Lab Capacity • 1 Capacity • Usual PCR testing 140/day • Capacity now of 1,600 tests/day – 11-fold increase C A P A C I T Y Current lab capacity from 24 ’ A pr 2020 = 1,000 2 Operating Hours Maintained lab capacity of 1,000 tests/day • Long hours (staggered), 7 days a week • Staff rostered on call 24/7 for urgent tests 3 Supply chain • Ensure sustainability of consumables and devices 4 Buffer Capacity • Possible surge in testing and possibly cases

  12. Framework Capacity Capability COVID-19 Management Command Culture

  13. Developing Capability Clinical Capability  Prepared to ramp up from 62 to ~214 ICU beds  Room, equipment, people (ICU course), consumables C A P A B I L I T Y Infection Prevention and Control  PPE and IPC practice, Safe Distancing  Contact tracing, mask fitting Leadership Capability and Teaming  Developmental opportunity – trial of fire  Recognition of co-dependency  Building trust Innovation and Creativity  Necessity is the Mother of Invention

  14. Developing Capability and Capacity SGH Campus Approach  Trust and Understanding C A P A B I L I T Y  Collaboration and Teamwork  Coordinated effort by joint team from  SGH  NDCS  SNEC  NCCS  NHCS  NNI  All SingHealth institutions collaborating, sharing, exchanging with all clusters

  15. Testing Capability • 1 Manpower • Cross-training of colleagues – other labs, research labs C A P A B I L I T Y 2 • Tests and Systems • Started with in-house testing based on WHO test • MOH-developed test • High throughput platform (1-2-3 machines) 3 Digitalisation of Process • Registration, labelling, lab tracking • From paper to laptop 4 Consumables • Dacron swabs, Copan/Miraclean swabs • 3-D and IM swabs

  16. Role Beyond the Hospital C A P A B I L I T Y CCF Operations Dormitory Ops Moving Downstream Moving Upstream - facilitate discharge - reduce attendance - bypass admission - bypass admission

  17. Supporting External Operations Dormitory Operations • Sharp rise in the number of cases in the dormitories • Essential to move Upstream to manage COVID-19 patients C A P A B I L I T Y • National effort to support more vulnerable • Deployment of staff to the following: • 8 Dormitories - ~40,000 patients seen • 2 Swab Isolation Facilities (SIFs) • 1 Community Care Facility (CCFs) • Provide essential primary care and screening - swab testing

  18. Swiftly Swung into Action to Support External Ops Swab Isolation Facility C A P A B I L I T Y Community Care Facility - Expo

  19. Swiftly Swung into Action to Support External Ops Objectives in Community Care Facility (CCF): • Zero transmission to Healthcare Workers • Zero adverse event to patient C A P A B I L I T Y • Innovate to:  Reduce transmission risk  Good patient experience  Enhance value Nurse Station

  20. Conducted ~20,000 mobile swabs and mass serology tests [1] 25000 25,000 Mobile Swabs (Cumulative) Serology Tests (Cumulative) 21,281 19,817 17,773 20000 20,000 13,758 12,754 15000 15,000 C A P A B I L I T Y 10000 10,000 4398 5000 5,000 2,418 0 0 Apr May Jun Jul May Jun Jul [1] Based on number of tests conducted by SGH Serology Team

  21. Relatively Low Case Fatality and Population Fatality Population Fatality (per 100,000 people): 0.47 As of 2019, population of SG is 5.70 million [1] Case Fatality Rate: 0.05% Outcomes (27/55,104) [1] Department of Statistics Singapore

  22. Framework Capacity Capability COVID-19 Management Command Culture

  23. Leadership Structure • Early recognition of value of coordination and load Concerted National Effort - MMT (Multi-Ministry T askforce) levelling at national level – patients and staff • Standardised criteria for • Suspect cases, admission, testing, • Transfer to step-down care facilities • PPE usage • Engagement and 2-way communication • Consolidation and/Rationalisation of • Supply chain and procurement • Manpower and resource deployment SingHealth Disease Outbreak Taskforce (SDOT) • Cluster and Institutional Leadership • Domain Leads • Reporting and tracking outcomes and supplies • Harmonisation of Policies • PPE, IPC SDOT visit to Ward@Bowyer SDOT • HR preparing gift packs for staff

  24. Crisis Leadership – Establishing Authority of Domain Experts “ Central Focus on COVID-19 ” • Early establishment of command center to navigate whirlwind of activities • Collective leadership with a flattened hierarchy • Primarily led by domain experts e.g. ID & IPE while C O M M A N D Management took a supportive role • Clinical protocols continually reviewed From L-R: InfectiousDisease department led by Dr Tan Thuan Tong, Dr Limin and Dr Indumathi Source: McKinsey & Company Dr Ling Moi Lin, Dr Kenneth Tan, Prof Tan Ban Hock, Infectious Prevention Department of Chief Quality Officer, & Epidemiology Emergency Medicine W68 Nursing Colleagues Preparedness & Response Colleagues SGH department

  25. Decision Making is Backed by Data  T aking reference from Global & National Intelligence  Launch of thrice daily COVID-19 Dashboard with the use of T ableau Visualizer T ool • Reduce increasingly laborious manual efforts • Reduce strain on duplicative reporting across frontline C O M M A N D departments John Hopkins University COVID-19 Dashboard • Provide a holistic one-source view of key reporting metrics of Covid vs Non-covid for management oversight UpCode Academy SG COVID-19 Dashboard SGH COVID-19 Dashboard

  26. Framework Capacity Capability COVID-19 Management Culture Command

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend